Sign in
Join
Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Search
Type here...
Search
Home
Trending
Analysis
Research Reports
Contact Us
My account
Get into your account.
Login
Register
Search
My account
Get into your account.
Login
Register
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
Twitter
Youtube
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
Twitter
Youtube
Home
Trending
Analysis
Research Reports
Contact Us
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Home
Trending
Analysis
Research Reports
Contact Us
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Tag:
Healthcare
Healthcare
Technology & AI
M&A
Healthcare
Consumer & Retail
Media & Entertainment
BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination
Healthcare
Ishan Majumdar
-
December 20, 2025
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...
Eli Lilly Adverum Acquisition Could Reshape Gene Therapy!
Healthcare
Ishan Majumdar
-
December 19, 2025
Eli Lilly (NYSE:LLY) isn’t slowing down. After a quarter filled with blockbuster drug launches, accelerated global uptake of Mounjaro...
Mirum Bluejay Acquisition Unlocks Rare Disease Gold!
Healthcare
Ishan M.
-
December 19, 2025
Mirum Pharmaceuticals (NASDAQ:MIRM) is making big moves. In early December 2025, the company announced its plan to acquire privately...
Novartis Gene Therapy Approval: A New Multi-Billion Dollar Market?
Healthcare
Ishan M.
-
December 19, 2025
Novartis just scored a big win with a major Novartis gene therapy approval —and it could reshape the gene...
Abbott Exact Sciences Acquisition: $21B Cancer Gamble
M&A
Ishan Majumdar
-
December 19, 2025
Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...
Johnson & Johnson Halda Acquisition: The $3.05 Billion Gamble!
Healthcare
Ishan Majumdar
-
December 19, 2025
Johnson & Johnson just made another big move. The company announced that it will buy Halda Therapeutics for $3.05...
Merck Cidara Acquisition: $9.2B Flu Drug Deal to Replace Keytruda
Healthcare
Ishan Majumdar
-
December 19, 2025
Merck isn’t waiting around for Keytruda’s patent clock to run out. On November 14, the pharma giant announced its...
Cogent Biosciences’ Cancer Drug Exploded to 136% —Can the Rally Actually Last?
Healthcare
Ishan Majumdar
-
December 19, 2025
It’s not every day you see a biotech stock jump 136% before lunch. But that’s exactly what happened with...
Premier Inc. Draws Buyout Interest From Patient Square Capital — Here’s Why This Deal Could Happen
Healthcare
Ishan Majumdar
-
December 19, 2025
Premier Inc, a healthcare group purchasing and technology company, has recently become the subject of acquisition interest from private...
GE Healthcare’s Neurology Bet: Can The Icometrix Acquisition Unlock The Alzheimer’s Diagnosis Market?
Healthcare
Ishan Majumdar
-
December 19, 2025
GE HealthCare has deepened its push into precision medicine with a strategic agreement to acquire icometrix, a Belgium-based firm...
Jamf Holding’s $1.4 Billion Shakeup: Citigroup Tapped As Vista Plots Its Exit
Healthcare
Ishan Majumdar
-
December 19, 2025
Jamf Holding Corp., a leading Apple-focused device management and security software provider, has become the subject of renewed M&A...
Kenvue Crashing?—New RFK Jr. Report May Blame Tylenol Use In Pregnancy For Autism
Healthcare
Ishan Majumdar
-
December 19, 2025
Shares of Kenvue Inc., maker of Tylenol, dropped roughly 10% in early September 2025 after media reports—primarily from The...
Load more
BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination
Healthcare
Ishan Majumdar
-
December 20, 2025
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...
Eli Lilly Adverum Acquisition Could Reshape Gene Therapy!
Healthcare
Ishan Majumdar
-
December 10, 2025
Eli Lilly (NYSE:LLY) isn’t slowing down. After a quarter filled with blockbuster drug launches, accelerated global uptake of Mounjaro...
Mirum Bluejay Acquisition Unlocks Rare Disease Gold!
Healthcare
Ishan M.
-
December 9, 2025
Mirum Pharmaceuticals (NASDAQ:MIRM) is making big moves. In early December 2025, the company announced its plan to acquire privately...
Novartis Gene Therapy Approval: A New Multi-Billion Dollar Market?
Healthcare
Ishan M.
-
November 26, 2025
Novartis just scored a big win with a major Novartis gene therapy approval —and it could reshape the gene...
Abbott Exact Sciences Acquisition: $21B Cancer Gamble
M&A
Ishan Majumdar
-
November 21, 2025
Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...
Johnson & Johnson Halda Acquisition: The $3.05 Billion Gamble!
Healthcare
Ishan Majumdar
-
November 18, 2025
Johnson & Johnson just made another big move. The company announced that it will buy Halda Therapeutics for $3.05...
Merck Cidara Acquisition: $9.2B Flu Drug Deal to Replace Keytruda
Healthcare
Ishan Majumdar
-
November 15, 2025
Merck isn’t waiting around for Keytruda’s patent clock to run out. On November 14, the pharma giant announced its...
Cogent Biosciences’ Cancer Drug Exploded to 136% —Can the Rally Actually Last?
Healthcare
Ishan Majumdar
-
November 12, 2025
It’s not every day you see a biotech stock jump 136% before lunch. But that’s exactly what happened with...
Premier Inc. Draws Buyout Interest From Patient Square Capital — Here’s Why This Deal Could Happen
Healthcare
Ishan Majumdar
-
September 25, 2025
Premier Inc, a healthcare group purchasing and technology company, has recently become the subject of acquisition interest from private...
GE Healthcare’s Neurology Bet: Can The Icometrix Acquisition Unlock The Alzheimer’s Diagnosis Market?
Healthcare
Ishan Majumdar
-
September 25, 2025
GE HealthCare has deepened its push into precision medicine with a strategic agreement to acquire icometrix, a Belgium-based firm...
Jamf Holding’s $1.4 Billion Shakeup: Citigroup Tapped As Vista Plots Its Exit
Healthcare
Ishan Majumdar
-
September 25, 2025
Jamf Holding Corp., a leading Apple-focused device management and security software provider, has become the subject of renewed M&A...
Kenvue Crashing?—New RFK Jr. Report May Blame Tylenol Use In Pregnancy For Autism
Healthcare
Ishan Majumdar
-
September 25, 2025
Shares of Kenvue Inc., maker of Tylenol, dropped roughly 10% in early September 2025 after media reports—primarily from The...